Labiotech.eu

Inside Labiotech 12 Feb 2019

Why We Love Being the Main Media Partner of BIO-Europe

We love partnering with cool people and companies—in return, we get to be in the middle of the action, get our name out there, and bring you all the very best of the events we attend. One of our favorite partnerships is with EBD Group, which are running BIO-Europe. Here’s why we love partnering with […]

February 12, 2019 - 2 minutesmins - By Philip Hemme

grey wolf therapeutics cancer immunotherapies

News and Trends 11 Feb 2019

Series A to Fund Therapy That Exposes Cancer to Immune System

The UK biotech Grey Wolf Therapeutics has raised €11.4M (£10M) to fuel the development of a cancer therapy that flushes tumor cells out of hiding from the immune system. Many approved cancer immunotherapies, such as CAR-T cell therapy and checkpoint inhibitors, have made a big difference for many people with cancer. However, a common problem with […]

February 11, 2019 - 2 minutesmins - By Jonathan Smith

In Depth 11 Feb 2019

CRISPR: One Patent to Rule Them All

The gene editing tool CRISPR-Cas9 has revolutionized research in biology. With several parties fighting for the rights to the technology’s intellectual property, how difficult is it for third parties to access this coveted technology? The CRISPR patent dispute is quite unique. While universities usually work together to disseminate innovation and knowledge, in the CRISPR case […]

February 11, 2019 - 5 minutesmins - By Timothé Cynober

equi nom israel genomics selective breeding legume

Startup Scout 8 Feb 2019

This Biotech Uses Genomics to Breed Super Peas

This week’s biotech, Equi-Nom, is based in Israel. With its genomics and computer modeling technology, the company helps plant producers to breed pulses that contain more protein without any genetic modification. Mission: To boost the protein content in pulses, such as peas, without editing their DNA. Instead, the company speeds up traditional breeding by […]

February 8, 2019 - 4 minutesmins - By Jonathan Smith

More News! 8 Feb 2019

Swiss Firm Launches Cancer Test That Gives Results in Minutes

Lunaphore Technologies has launched a device for automated testing of cancer tissue samples that gives results in under 30 minutes. Lunaphore has developed a piece of next-generation equipment to perform immunohistochemistry (IHC) tests, a common technique used to find specific cancer biomarkers in tissue samples from cancer patients after a biopsy. The equipment, called LabSat, will […]

February 8, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

CRISPR Cas9 bacteriophage anti CRISPR gut microbiome 1

News and Trends 8 Feb 2019

Anti-CRISPR Proteins Could Improve Gene Editing Precision

A research group in Denmark has found proteins in gut and soil microbes that can inhibit the action of CRISPR-Cas9 gene editing, a finding that could help to control the technology with more precision and less risk. Bacteria and viruses have fought an evolutionary arms race for millions of years. Bacteria evolved CRISPR systems to […]

February 8, 2019 - 3 minutesmins - By Jonathan Smith

More News! 6 Feb 2019

British Biotech Spin-Offs Get €40M Funding to Treat Narcolepsy

Orexia and Inexia, two new virtual companies spun out of Sosei Heptares, will develop drugs for neurological diseases such as narcolepsy with funding from Medicxi Ventures. The companies will develop drugs that activate two molecules called OX1 and OX2. These molecules act as receptors of orexin, a protein that regulates arousal, wakefulness and sleep. The […]

February 6, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

breast cancer metformin klefstrom checkpoint inhibitor thumbnail

News and Trends 6 Feb 2019

Combo of Immunotherapy and Diabetes Drug Could Beat Breast Cancer

A Finnish research group has combined two cancer drugs with the diabetes drug metformin, making mice with breast cancer survive for longer than when given the treatments individually. The combination therapy included metformin, which can inhibit tumor growth; the cancer drug venetoclax, which causes cancer cells to commit suicide; and a checkpoint inhibitor antibody, which […]

February 6, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 6 Feb 2019

Engineered Chicken Eggs: The Future of Cheap Drug Production?

Scientists at the University of Edinburgh have produced high-quality human proteins in chicken eggs, a method that could be significantly cheaper than the current standard. The researchers engineered the DNA of chickens to make them produce human proteins in the egg white, from where they can be easily purified. In a study published on the […]

February 6, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

elypta renal cell carcinoma kidney blood cancer

News and Trends 4 Feb 2019

Swedish Biotech Receives EU Grant for High-Accuracy Kidney Cancer Test

The Swedish biotech Elypta has received a Horizon 2020 grant of €2.4M to fund a clinical trial of a blood and urine test that provides an accurate diagnosis of renal cell carcinoma. The clinical trial aims to validate Elypta’s technology as a monitoring tool in patients who have been treated for the kidney cancer renal […]

February 4, 2019 - 2 minutesmins - By Jonathan Smith

Startup Scout 1 Feb 2019

This Biotech Links the Gut Microbiome to Diseases Using Norwegian Poo

In Norway’s capital city of Oslo, the biotech Bio-Me can rapidly screen for specific gut bacteria, gathering data from thousands of Norwegian stool samples to link the gut microbiome to diseases. Mission: To rapidly screen thousands of stool samples from a Norwegian population study and link the gut microbiome with disease. Client companies will then […]

February 1, 2019 - 4 minutesmins - By Jonathan Smith

More News! 31 Jan 2019

Watch Strap Made of Recombinant Spider Silk Launches in Europe

Sold by the luxury brand Omega, the watch strap is made with spider silk proteins that are brewed by genetically engineered bacteria. Spider silk is known in the textile industry for its strength, resilience, flexibility and light weight. However, it is not possible to ‘farm’ spiders to produce their silk at an industrial scale. The […]

January 31, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Why We Love Being the Main Media Partner of BIO-Europe

Series A to Fund Therapy That Exposes Cancer to Immune System

CRISPR: One Patent to Rule Them All

This Biotech Uses Genomics to Breed Super Peas

Swiss Firm Launches Cancer Test That Gives Results in Minutes

Anti-CRISPR Proteins Could Improve Gene Editing Precision

British Biotech Spin-Offs Get €40M Funding to Treat Narcolepsy

Combo of Immunotherapy and Diabetes Drug Could Beat Breast Cancer

Engineered Chicken Eggs: The Future of Cheap Drug Production?

Swedish Biotech Receives EU Grant for High-Accuracy Kidney Cancer Test

This Biotech Links the Gut Microbiome to Diseases Using Norwegian Poo

Watch Strap Made of Recombinant Spider Silk Launches in Europe

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!